UBS Asset Management

UBS Asset Management is a global investment manager offering alternative and quantitative investments, global real estate, infrastructure & private equity, and fund services. It manages separate client-focused equity, fixed income, and balanced portfolios, investing in public markets worldwide using fundamental and quantitative analysis.

https://crunchbase.com/organization/***

https://linkedin.com/company/***

https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=2337367

https://www.privateequityinternational.com/database/#/profile?id=1386

Faisal Alshibl

Director

Baljit Basi

Investment Bank Principal Investments

Hyunja Laski

Principal

Mark Mackenzie

MD - Private Placements

Neal McMinn

Executive Director

Tom Naratil

Co-President Global Wealth Management and President UBS Americas

Steffan Peyer

Analyst Intern

Laurenz Simbruner

Associate Director

Todd Tuckner

CFO and Head Business Performance and Risk Management for Global Wealth Management

Patrick Yip

Associate

Past deals in Serbia

Swixx Biopharma

Debt Financing in 2021

Swixx Biopharma is a specialized company that provides comprehensive representation for biopharma, over-the-counter (OTC), and medical device firms in Central and Eastern Europe (CEE). Founded in 2014 and based in Baar, Switzerland, Swixx Biopharma operates fully-owned affiliates across various CEE countries, including Albania, Bulgaria, Poland, and Romania, among others. The company aims to fill the gap left by multinational corporations that choose not to enter or exit specific markets or therapeutic areas. With a focus on rare diseases, oncology-hematology, specialty treatments, and self-medication, Swixx Biopharma leverages its research expertise to deliver effective health solutions tailored to the needs of the region.

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.